Objectives Our primary objective was to quantify damage burden measured by Damage
Index for Antiphospholipid Syndrome (DIAPS) in aPL-positive patients with or without a …

Background Despite anticoagulant therapy, a antiphospholipid syndrome (APS) has a
higher rate of recurrent events, which can lead to damage accrual and a negative impact on …

Background Antiphospholipid syndrome (APS) is a rare autoimmune disease characterized
by thromboses at various sites and obstetric events associated with the persistent presence …

Objective To analyse the association between the average 'adjusted'Global APS Score
(aGAPSS) over time, as a surrogate of disease activity, and change in Damage Index for …

Objectives We aim to independently assess the validity of the damage index for
antiphospholipid syndrome (DIAPS) in thrombotic antiphospholipid syndrome (APS) patients …

Background. Pregnancy in systemic lupus erythematosus (SLE) patients is a challenge due
to the potential maternal and fetal complications. Therefore, a multidisciplinary assessment …

Factores de predicción relevantes en la supervivencia de pacientes con síndrome
antifosfolípido Relevants predictions factors Page 1 …

Points clés• Les critères de classification du SAPL viennent d'être révisés en 2023, en
suivant une méthodologie rigoureuse recommandée par les sociétés savantes …

Background. Pregnancy in systemic lupus erythematosus (SLE) patients is a challenge due
to the potential maternal and fetal complications. Therefore, a multidisciplinary assessment …

Antecedentes: El síndrome de anticuerpos antifosfolípidos primario (SAFp) es una
enfermedad autoinmune sistémica con diversas formas de presentación. Existe información …